Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Diamyd

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Diamyd Medical highlights Type 1 Diabetes prevention, Phase 3
    Diamyd Medical highlights Type 1 Diabetes prevention, Phase 3

    21 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/diamyd-medical-highlights-opportunity-in-type-1-diabetes-prevention-adult-onset-market-and-upcoming-phase-3-readout-302433254.html

    PR NEWSWIRE
    21 Apr 2025
    Share Share
    Diamyd Medical Pursues Accelerated Approval For T1D Precision Medicine
    Diamyd Medical Pursues Accelerated Approval For T1D Precision Medicine

    09 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/diamyd-medical-to-pursue-accelerated-approval-pathway-for-type-1-diabetes-precision-medicine-302241745.html

    PR NEWSWIRE
    09 Sep 2024
    Share Share
    Diamyd® Phase 3 Trial Recruitment Milestone
    Diamyd® Phase 3 Trial Recruitment Milestone

    12 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/recruitment-milestone-reached-in-diamyd-phase-3-trial-302115296.html

    PR NEWSWIRE
    12 Apr 2024
    Share Share
    Promising topline results for intralymphatic Diamyd® in patients with LADA
    Promising topline results for intralymphatic Diamyd® in patients with LADA

    07 Jul 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/promising-topline-results-for-intralymphatic-diamyd-in-patients-with-lada-301582386.html

    PRNEWSWIRE
    07 Jul 2022
    Share Share